Join AAJLJ and JLens for a conversation with Allison Marill, Director of Research at JLens, on how Jewish investors can combat anti-Israel activism and antisemitism in the corporate world.

Allison will discuss 2026 trends, including the growing wave of BDS-aligned shareholder proposals at major U.S. companies, and how shareholder advocacy can advance Jewish communal priorities. She will also share JLens’ research on the potential financial costs of divesting from Israel for pension funds and university endowments.

October 21, 2026 | 12:00 PM ET | Zoom Webinar